25.43USD-5.78%Mkt Cap: 4.71B USDP/E: —Last update: 2026-06-01
Legend Biotech Corporation, through its subsidiaries, operates as a biopharmaceutical company that discovers, develops, manufactures, and commercializes novel cell therapies for oncology and other indications in the Unit…
Industry Peers
Biotechnology111.39BUSDP/E 26.0
100.62BDKKP/E 19.4
62.97BUSDP/E 14.7
48.39BEURP/E 31.7
44.65BEURP/E 37.2
40.10BUSDP/E 75.3
35.22BUSD—
32.91BSEKP/E 48.6
Indicators:|
Key Statistics
Company
Market Cap4.71B USD
Enterprise Value9.64B USD
Revenue (TTM)1.14B USD
Gross Profit620.80M USD
Net Income (TTM)-296.80M USD
Revenue/Share6.168 USD
Last Price25.43 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees3.1K
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)20.34
PEG—
EV/EBITDA-77.09
EV/Revenue8.47
P/S4.43
P/B5.01
EPS (TTM)-1.38
EPS (Forward)1.33
52W Range
16.2432% of range45.30
52W High45.30 USD
52W Low16.24 USD
Profitability
Gross Margin60.34%
Oper. Margin-16.32%
EBITDA Margin-10.98%
Profit Margin-28.85%
ROE-29.62%
ROA-17.12%
Growth
Revenue Growth56.50%
Earnings Growth—
Cash Flow & Leverage
Operating CF-100.20M USD
CapEx (TTM)28.60M USD
FCF Margin-4.90%
FCF Yield-1.18%
Net Debt-445.30M USD
Net Debt/EBITDA3.56
Balance Sheet
Debt/Equity0.41
Current Ratio2.13
Quick Ratio2.01
Book Value/Sh5.418 USD
Cash/Share2.247 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating1.6 (Buy)
Target (Mean)55.39 USD
Target Range27.00 USD – 86.00 USD
# Analysts15
Ownership
Shares Out.185.74M
Float164.99M
Insiders1.31%
Institutions54.07%
Short Interest
Short Ratio4.9d
Short % Float19.64%
Short % Out.7.77%
Shares Short14.43M
Short (prev mo.)19.22M
Technical
SMA 5023.00 (+10.6%)
SMA 20025.94 (-2.0%)
Beta0.30
S&P 52W Chg27.94%
Avg Vol (30d)2.47M
Avg Vol (10d)1.63M
Technical Indicators
RSI (14)52.4
MACD1.3519
MACD Signal1.6361
MACD Hist.-0.2841
BB Upper30.60 USD
BB Middle27.80 USD
BB Lower25.00 USD
BB Width20.14%
ATR (14)1.783 USD
Vol Ratio (20d)0.70x